MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population

NAUnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

July 15, 2023

Study Completion Date

November 30, 2023

Conditions
Health Screening
Interventions
DEVICE

MyoVista wavECG

A standard 12-Lead, multi-channel resting interpretive trans-thoracic electrocardiograph providing both a Glasgow Interpretive Analysis and unique MyoVista wavECG Information for the detection of Left Ventricular Diastolic Dysfunction.

Trial Locations (1)

75390

University of Texas Medical Center, Dallas

Sponsors
All Listed Sponsors
lead

Heart Test Laboratories, Inc.

INDUSTRY